Vlad Vitoc
Chief Executive Officer at MAIA BIOTECHNOLOGY, INC.
Net worth: 3 M $ as of 2024-04-29
Profile
Dr. Vlad Vitoc is a Chairman, President & Chief Executive Officer at MAIA Biotechnology, Inc. and a Chief Executive Officer & Director at DGD Pharmaceuticals Corp.
He is on the Board of Directors at DGD Pharmaceuticals Corp.
He received his MBA from the University of South Carolina and a doctorate degree from Iuliu Hatieganu University of Medicine & Pharmacy.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
MAIA BIOTECHNOLOGY, INC.
4.95% | 2024-04-25 | 1,019,121 ( 4.95% ) | 3 M $ | 2024-04-29 |
Vlad Vitoc active positions
| Companies | Position | Start |
|---|---|---|
| MAIA BIOTECHNOLOGY, INC. | Chief Executive Officer | 2018-08-02 |
DGD Pharmaceuticals Corp.
 DGD Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology DGD Pharmaceuticals engages in the development of drug for cancer therapies. It offers DGD1202, targets cancer cell and help prevent to mutate into EGFR. The company was founded by Mukesh Nyati and is headquartered in Chicago, IL. | Chief Executive Officer | - |
Training of Vlad Vitoc
| Iuliu Hatieganu University of Medicine & Pharmacy | Doctorate Degree |
| University of South Carolina | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| MAIA BIOTECHNOLOGY, INC. | Health Technology |
| Private companies | 1 |
|---|---|
DGD Pharmaceuticals Corp.
DGD Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology DGD Pharmaceuticals engages in the development of drug for cancer therapies. It offers DGD1202, targets cancer cell and help prevent to mutate into EGFR. The company was founded by Mukesh Nyati and is headquartered in Chicago, IL. | Health Technology |
- Stock Market
- Insiders
- Vlad Vitoc
